DIO2 Thr92Ala Reduces Deiodinase-2 Activity and Serum-T3 Levels in Thyroid-Deficient Patients
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
DIO2 Thr92Ala Reduces Deiodinase-2 Activity and Serum-T3 Levels in Thyroid-Deficient Patients
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Volume 102, Issue 5, Pages 1623-1630
Publisher
The Endocrine Society
Online
2017-04-19
DOI
10.1210/jc.2016-2587
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Selective Loss of the Type 2 Iodothyronine Deiodinase in Mouse Thyrotrophs Increases Basal TSH but Blunts the Thyrotropin Response to Hypothyroidism
- (2015) Cristina Luongo et al. ENDOCRINOLOGY
- Prevalent Polymorphism in Thyroid Hormone-Activating Enzyme Leaves a Genetic Fingerprint That Underlies Associated Clinical Syndromes
- (2015) Elizabeth A. McAninch et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Intracellular Inactivation of Thyroid Hormone Is a Survival Mechanism for Muscle Stem Cell Proliferation and Lineage Progression
- (2014) Monica Dentice et al. Cell Metabolism
- Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement
- (2014) Jacqueline Jonklaas et al. THYROID
- TSH-suppressive doses of levothyroxine are required to achieve preoperative native serum triiodothyronine levels in patients who have undergone total thyroidectomy
- (2012) Mitsuru Ito et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Levothyroxine Monotherapy Cannot Guarantee Euthyroidism in All Athyreotic Patients
- (2011) Damiano Gullo et al. PLoS One
- Association of the type 2 deiodinase Thr92Ala polymorphism with type 2 diabetes: case–control study and meta-analysis
- (2010) José Miguel Dora et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- The FoxO3/type 2 deiodinase pathway is required for normal mouse myogenesis and muscle regeneration
- (2010) Monica Dentice et al. JOURNAL OF CLINICAL INVESTIGATION
- The Thr92Ala 5′ Type 2 Deiodinase Gene Polymorphism Is Associated with a Delayed Triiodothyronine Secretion in Response to the Thyrotropin-Releasing Hormone–Stimulation Test: A Pharmacogenomic Study
- (2010) Peter W. Butler et al. THYROID
- Type 2 Iodothyronine Deiodinase in Human Skeletal Muscle: New Insights into Its Physiological Role and Regulation
- (2009) P. Reed Larsen JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Association of genetic polymorphisms in the type II deiodinase gene with bipolar disorder in a subset of Chinese population
- (2009) Bing He et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Thr92Ala polymorphism in the type 2 deiodinase is not associated with T4 dose in athyroid patients or patients with Hashimoto thyroiditis
- (2008) K. A. Heemstra et al. CLINICAL ENDOCRINOLOGY
- Triiodothyronine Levels in Athyreotic Individuals During Levothyroxine Therapy
- (2008) Jacqueline Jonklaas JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Type 2 Deiodinase Polymorphism (Threonine 92 Alanine) Predictsl-Thyroxine Dose to Achieve Target Thyrotropin Levels in Thyroidectomized Patients
- (2007) Massimo Torlontano et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation